Look for:

Our offer for

VERTEX PHARMACEUTICAL


ISIN:
US92532F1003
WKN:
92532F100

2022/01/18 20:31:31
Price
230.41 USD
Difference -1.56% (-3.65)

General attributes

ISINUS92532F1003
SymbolVRTX
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)52,158 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)230.37 USD (100)
Ask (Ask size)230.64 USD (200)
Open231.43 USD
High232.49 USD
Low228.74 USD
Close (prev. day)234.06 USD
VWAP230.506834 USD
Volume (pcs)1,188,408
Trading volume273,920,775.01
Number of trades24,478
Last size100

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: VERTEX PHARMACEUTICALPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/01/18 20:31:31
Price
230.41 USD
Difference -1.56% (-3.65)

General attributes

ISINUS92532F1003
SymbolVRTX
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)52,158 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)230.37 USD (100)
Ask (Ask size)230.64 USD (200)
Open231.43 USD
High232.49 USD
Low228.74 USD
Close (prev. day)234.06 USD
VWAP230.506834 USD
Volume (pcs)1,188,408
Trading volume273,920,775.01
Number of trades24,478
Last size100

Performance and Risk

6m1Y3Y
Perf (%)+18.28%+3.51%+27.27%
Perf (abs.)+36.17+7.94+50.15
Beta0.320.430.79
Volatility23.8726.2134.84
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)227.38 USD (1,691,500)
Ø price 30 days | Ø volume 30 days (pcs.)217.63 USD (1,672,277)
Ø price 100 days | Ø volume 100 days (pcs.)196.42 USD (1,697,688)
Ø price 250 days | Ø volume 250 days (pcs.)203.99 USD (1,954,522)
YTD High | date234.58 USD (2022/01/14)
YTD Low | date214.66 USD (2022/01/03)
52 Weeks High | date242.99 USD (2021/01/25)
52 Weeks Low | date176.36 USD (2021/10/06)

All listings for VERTEX PHARMACEUTICAL

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/01/1817:35202.60 EUR0.2742
Vienna Stock Exchange2022/01/1817:32202.95 EUR0.059
Tradegate2022/01/1820:20203.30 EUR0.3570
Stuttgart2022/01/1818:55203.80 EUR0.004
Nasdaq2022/01/1820:31230.41 USD273.9224,478
Munich2022/01/1808:00204.05 EUR0.001
London Stock Exchange2022/01/1815:53231.00 USD0.0111
Hanover2022/01/1808:01204.05 EUR0.001
Hamburg2022/01/1808:01204.05 EUR0.001
Frankfurt2022/01/1808:42205.45 EUR0.003
Duesseldorf2022/01/1819:01203.80 EUR0.0010
Berlin2022/01/1808:08204.00 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=15368&ID_TYPE_IMAGE_LOGO=2

Contact Details

VERTEX PHARMACEUTICALS INC.
- -
50 Northern Avenue - 02210 Boston
Telefon: 1-617-341-6100
Fax: -
E-mail: mediainfo@vrtx.com

PDF Downloads

Company report: VERTEX PHARMACEUTICALPDF Download

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Members of Management Board

Jeffrey LeidenChairman of Board of Directors
Alan GarberMember of Board of Directors
Sangeeta BhatiaMember of Board of Directors
Bruce SachsMember of Board of Directors
Diana McKenzieMember of Board of Directors
Lloyd CarneyMember of Board of Directors
Margaret McGlynnMember of Board of Directors
Terrence KearneyMember of Board of Directors
Yuchun LeeMember of Board of Directors
Reshma KewalramaniChairman of Managing Board
Bastiano SannaMember of Executive Committee
Carmen BozicMember of Executive Committee
David AltshulerMember of Executive Committee
Nia TatsisMember of Executive Committee
Amit SachdevMember of Executive Committee
Charles WagnerMember of Executive Committee
Damian WilmotMember of Executive Committee
Ludovic FenauxMember of Executive Committee
Michael PartridgeMember of Executive Committee
Mike TirozziMember of Executive Committee
Stephanie FranklinMember of Executive Committee
Stuart ArbuckleMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer